levodopa has been researched along with risperidone in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alessandria, A; Bonifati, V; Giustini, P; Meco, G | 1 |
| Damecour, CL; Turcotte, JR | 1 |
| Alessandri, A; Bonifati, V; Giustini, P; Meco, G | 1 |
| Alessandri, A; Bonifati, V; Fabrizio, E; Meco, G; Vanacore, N | 1 |
| Allen, SM; Davis, WM; Freeman, JN | 1 |
| Kesler, S; Niehaus, DJ; Seedat, S; Stein, DJ | 1 |
| Kato, K; Kawakatsu, S; Otani, K; Wada, T | 1 |
| Hoefnagels, WH; Horstink, MW; Scheepmaker, AJ; Strijks, FE | 1 |
| Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F | 1 |
| Grabli, D; Hartmann, A; Lebreton, M; Palminteri, S; Pessiglione, M; Worbe, Y | 1 |
| Arakawa, R; Ito, H; Kodaka, F; Miyoshi, M; Okumura, M; Otsuka, T; Suhara, T; Takahashi, H; Takano, H | 1 |
| Abe, Y; Hirokawa, S; Kakita, A; Kato, T; Kominami, R; Nawa, H; Ozaki, M; Sotoyama, H; Takahashi, H | 1 |
| Gabriel, D; Guggisberg, A; Morand, S; Nahum, L; Schnider, A | 1 |
| Alicart, H; Antonijoan, RM; Ferreri, L; Gómez-Andrés, A; Marco-Pallares, J; Mas-Herrero, E; Noesselt, T; Riba, J; Ripollés, P; Rodriguez-Fornells, A; Valle, M | 1 |
| Alicart, H; Antonijoan, RM; Ferreri, L; Gomez-Andres, A; Marco-Pallarés, J; Mas-Herrero, E; Olivé, G; Riba, J; Ripollés, P; Rodriguez-Fornells, A; Valle, M; Zatorre, RJ | 1 |
4 trial(s) available for levodopa and risperidone
| Article | Year |
|---|---|
Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.
Topics: Aged; Antipsychotic Agents; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced; Risperidone; Severity of Illness Index; Time Factors | 1997 |
Risperidone in levodopa induced dyskinesiae.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Risperidone; Serotonin Antagonists; Severity of Illness Index | 1998 |
Dopaminergic modulation of rapid reality adaptation in thinking.
Topics: Adaptation, Psychological; Adult; Brain; Cognition Disorders; Dopamine; Dopamine Agents; Dopamine Antagonists; Double-Blind Method; Humans; Levodopa; Male; Memory; Memory Disorders; Mental Processes; Neural Inhibition; Neuropsychological Tests; Psychoses, Substance-Induced; Risperidone | 2010 |
Intrinsically regulated learning is modulated by synaptic dopamine signaling.
Topics: Adult; Carbidopa; Dopamine; Dopamine Agents; Dopamine Antagonists; Double-Blind Method; Female; Humans; Learning; Levodopa; Male; Memory, Long-Term; Reward; Risperidone; Signal Transduction; Synaptic Transmission; Young Adult | 2018 |
19 other study(ies) available for levodopa and risperidone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
Topics: Aged; Antipsychotic Agents; Hallucinations; Humans; Isoxazoles; Levodopa; Parkinson Disease; Piperidines; Risperidone | 1994 |
Therapeutic dilemma: psychosis and Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risperidone | 1995 |
Evaluation of risperidone in the neonatal 6-hydroxydopamine model of Lesch-Nyhan syndrome.
Topics: Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Disease Models, Animal; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Lesch-Nyhan Syndrome; Levodopa; Male; Motor Activity; Oxidopamine; Rats; Rats, Sprague-Dawley; Risperidone; Self Mutilation; Sympatholytics | 1998 |
Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents.
Topics: Antipsychotic Agents; Carbidopa; Dopamine Agonists; Drug Therapy, Combination; Female; Gambling; Humans; Impulsive Behavior; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Risperidone; Treatment Outcome | 2000 |
Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Brain; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Risperidone | 2002 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbamates; Cholinesterase Inhibitors; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Male; Neuroprotective Agents; Olanzapine; Phenylcarbamates; Pirenzepine; Risperidone; Rivastigmine; Treatment Outcome | 2003 |
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Remission Induction; Risperidone; Visual Perception | 2004 |
Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.
Topics: Adolescent; Adult; Avoidance Learning; Conditioning, Psychological; Cues; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Photic Stimulation; Reward; Risperidone; Subliminal Stimulation; Tourette Syndrome | 2009 |
Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?
Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Humans; Isoxazoles; Levodopa; Male; Paliperidone Palmitate; Positron-Emission Tomography; Putamen; Pyrimidines; Raclopride; Receptors, Dopamine D2; Rest; Risperidone; Synaptic Transmission; Young Adult | 2009 |
Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia.
Topics: Acoustic Stimulation; Animals; Animals, Newborn; Behavior, Animal; Biotinylation; Brain; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Gene Expression Regulation, Developmental; Hearing; Immunoprecipitation; Levodopa; Locomotion; Methamphetamine; Mice; Microdialysis; Neuregulin-1; Phosphorylation; Potassium; Proto-Oncogene Proteins c-fos; Reflex, Startle; Risperidone; Social Behavior; Statistics, Nonparametric; Tyrosine 3-Monooxygenase | 2011 |
Dopamine modulates the reward experiences elicited by music.
Topics: Administration, Oral; Adult; Auditory Perception; Brain; Dopamine; Dopamine Agonists; Emotions; Female; Humans; Levodopa; Male; Music; Placebo Effect; Pleasure; Reward; Risperidone; Young Adult | 2019 |